Tracking outcomes and side effects in GI and sarcoma cancers
Part of Cancer, Digestive system clinical trials.
This study follows adults with gastrointestinal cancer or sarcoma to better understand how patients do after treatment and what side effects happen. It may help researchers improve care for future patients by documenting real-world outcomes and toxicities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able and willing to sign consent and allow your health information to be shared
- You must be at least 18 years old when you sign consent
- You must have a confirmed gastrointestinal cancer or sarcoma (based on scans or biopsy/cell tests)
- If you can have a pregnancy or father a child, you may need to follow the study’s reproductive rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers information from people diagnosed with sarcoma (a bone or soft-tissue cancer) and their family members to learn what life is like after diagnosis. It is open to patients of any age, as well as their parents, caregivers, and older siblings.
This study collects tissue samples and medical data from people with sarcoma who are receiving or will receive immunotherapy. Its goal is to learn more about how these treatments work against sarcoma.
This study builds a clinical and biological database for people newly diagnosed with certain cancers. It may help doctors better understand cancer patterns and improve future care, and it involves agreeing to extra blood samples.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.
This study collects information and blood samples from adults with sarcoma who had surgery and possibly radiation. The goal is to build a large dataset that helps researchers understand sarcoma better and improve future care.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.